BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1063073)

  • 1. Increased erythrocytic and neutrophilic progenitors in myelofibrosis with myeloid metaplasia.
    Ohl S; Carsten AL; Chanana AD; Chikkappa G; Cronkite EP
    Eur J Cancer (1965); 1976 Feb; 12(2):131-5. PubMed ID: 1063073
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased granulocytic, erythrocytic, and megakaryocytic progenitors in myelofibrosis with myeloid metaplasia.
    Chikkappa G; Carsten AL; Chanana AD; Chandra P; Cronkite EP
    Am J Hematol; 1978; 4(2):121-31. PubMed ID: 677118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marrow fibrosis does not account for circulating CD34+ cells in myelofibrosis with myeloid metaplasia.
    Samuelson SJ; Popat U; Prchal JT
    Haematologica; 2007 Apr; 92(4):e47. PubMed ID: 17405759
    [No Abstract]   [Full Text] [Related]  

  • 4. Clonal analysis of agnogenic myeloid metaplasia.
    Kreipe H; Jaquet K; Felgner J; Parwaresch MR
    Leuk Lymphoma; 1992 Dec; 8(6):459-64. PubMed ID: 1363649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agnogenic myeloid metaplasia.
    Block M
    Rev Bras Pesqui Med Biol; 1974; 7(2):185-95. PubMed ID: 4527643
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell lineages in hematopoietic neoplasia studied with glucose-6-phosphate dehydrogenase cell markers.
    Fialkow PJ
    J Cell Physiol Suppl; 1982; 1():37-43. PubMed ID: 7040420
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical conference: Modes of blast transformation in chronic myeloid leukemia].
    Audebert AA; Zittoun R; Cadiou M; Bousser J
    Nouv Rev Fr Hematol; 1975; 15(2):270-8. PubMed ID: 126437
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia.
    Mesa RA; Li CY; Schroeder G; Tefferi A
    Blood; 2001 Jun; 97(11):3665-7. PubMed ID: 11369668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal granulocytes and bone marrow cells in the cellular phase of agnogenic myeloid metaplasia.
    Kreipe H; Jaquet K; Felgner J; Radzun HJ; Parwaresch MR
    Blood; 1991 Oct; 78(7):1814-7. PubMed ID: 1680495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelofibrosis with myeloid metaplasia with fatty bone marrow: report of a new case.
    Gerli GC; Gianelli U; Carraro MC; Bestetti A; Marchetti M; Barosi G
    Haematologica; 2001 Aug; 86(8):885-6. PubMed ID: 11524257
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical conference: Myelosclerosis and chronic myeloid leukemia].
    Waitz R; Mayer S; Mayer G; Oberling F
    Nouv Rev Fr Hematol; 1975; 15(2):213-28. PubMed ID: 126431
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythrophagocytosis by dysplastic neutrophils in chronic myelomonocytic leukemia and subsequent transformation to acute myeloid leukemia.
    Etzell J; Lu CM; Browne LW; Wang E
    Am J Hematol; 2005 Aug; 79(4):340-2. PubMed ID: 16044446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic progenitor cells in a patient with myeloid metaplasia without myelofibrosis.
    Kubota K; Tamura J; Kurabayashi H; Murakami H; Naruse T; Tsuchiya J
    J Med; 1992; 23(2):149-53. PubMed ID: 1512522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patho-anatomical features of the bone marrow.
    Lennert K; Nagai K; Schwarze EW
    Clin Haematol; 1975 Jun; 4(2):331-51. PubMed ID: 1102191
    [No Abstract]   [Full Text] [Related]  

  • 15. Culture studies of human pluripotent hemopoietic progenitors.
    Messner HA; Fauser AA
    Blut; 1980 Nov; 41(5):327-33. PubMed ID: 6934014
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro response to erythropoietin in erythroblastic transformation of chronic myelogenous leukemia.
    Greenberg BR; Hirasuna JD; Woo L
    Exp Hematol; 1980 Jan; 8(1):52-6. PubMed ID: 6931816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical conference: Prognostic factors in chronic myeloid leukemia. 798 observations].
    Jacquillat C; Chastang C; Tanzer J; Brière ; Weil M; Pereira-Neto M; Gemon-Auclerc MF; Schaison G; Domingo A; Boiron M; Bernard J
    Nouv Rev Fr Hematol; 1975; 15(2):229-40. PubMed ID: 126432
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating pluripotent haemopoietic cells in patients with myeloproliferative disorders.
    Douer D; Fabian I; Cline MJ
    Br J Haematol; 1983 Jul; 54(3):373-81. PubMed ID: 6574788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte progenitors (CFU-D) in neutrophilic leukemoid reaction are hyporesponsive to macrophage-induced inhibition.
    Hansz J; Sawiński K
    Res Exp Med (Berl); 1988; 188(3):217-25. PubMed ID: 3166525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic granulocytic leukemia in the aged.
    Conrad ME; Rappaport H; Crosby WH
    Arch Intern Med; 1965 Nov; 116(5):765-75. PubMed ID: 5215161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.